We report here that zinc supplementation in people reduced the prevalence and symptomatic decline of Alzheimer's disease, and that zinc deficiency in an Alzheimer's disease mouse model accelerated cognitive decline through potentiation of NLRP3-dependent inflammation, an effect that was reversible. The gene discussed is NLRP3; the disease is Alzheimer disease.